Greenbrook TMS Announces Participation in Upcoming Investor Conferences

TORONTO--(BUSINESS WIRE)--Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce that Bill Leonard, Chief Executive Officer, will participate in two upcoming virtual investor conferences.

Presentation Details:

Event: Canaccord Health & Wellness Virtual Conference 2020
Format: Panel- Mental Health Services
Date: Monday, November 23, 2020
Time: 11:00 a.m. (Eastern Time)

Event: Desjardins Digital Healthcare Conference 2020
Format: Corporate Presentation
Date: Tuesday, November 24, 2020
Time: 2:30 p.m. (Eastern Time)

About Greenbrook TMS Inc.

Operating through 125 Company-operated treatment centers, Greenbrook is a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 510,000 TMS treatments to over 14,000 patients struggling with depression.